In fact, chemotherapeutic agents including methotrexate and 5-FU targeting dihydrofolate reductase (DHFR) and thymidylate synthase (TYMS), two important enzymes involved in one-carbon metabolism, have been clinically applied in treatment of several types of cancer including CRC. This evidence concerns the gene TYMS and colorectal carcinoma.